Literature DB >> 17197927

Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.

Abbas Agaimy1, Peter H Wünsch, Ferdinand Hofstaedter, Hagen Blaszyk, Petra Rümmele, Andreas Gaumann, Wolfgang Dietmaier, Arndt Hartmann.   

Abstract

Multifocal hyperplasia of interstitial cells of Cajal (ICC hyperplasia) is a precursor of hereditary gastrointestinal stromal tumors (GISTs) in patients with germline mutations of c-KIT or PDGFRA, but precursor lesions of sporadic GISTs have not been defined yet. Small hyalinizing stromal tumors of the proximal stomach (referred to in this study as GIST tumorlets) were collected prospectively from 98 consecutive autopsies and additional cases were retrieved from surgical pathology files (total n=57). GIST tumorlets were grossly detectable in 22.5% consecutive autopsies performed in individuals older than 50 years. All lesions were located in the cardia, fundus, or proximal body, and ranged in size from 1 to 10 mm (4 mm). Similar lesions were not detected in the antrum, duodenum, and the remainder of the bowel. Histologically, the spindle cell subtype comprised all cases, with hyalinization and calcification in 57% of cases. The spindle cells were immunohistochemically positive for vimentin, CD117, and CD34. Twenty-four cases yielded sufficient DNA for subsequent molecular analysis, which showed c-KIT mutations in 11 cases (46%) and PDGFRA mutations in 1 case (4%). Sporadic GIST tumorlets of the proximal stomach are common in the general population over the age of 50 years and frequently show somatic c-KIT mutations. GIST tumorlets probably represent the grossly recognizable counterpart of sporadic ICC hyperplasia caused by somatic c-KIT or PDGFRA mutations. Early hyalinization and calcification seems to confer limited growth potential, and complete regression of such lesions is common. GIST tumorlets likely represent preclinical (preneoplastic) lesions that need additional stimuli to evolve into clinical GISTs, raising the possibility of a hyperplasia-neoplasia sequence in the development of sporadic GISTs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17197927     DOI: 10.1097/01.pas.0000213307.05811.f0

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  104 in total

Review 1.  Endoscopic management of gastrointestinal stromal tumors.

Authors:  Vinay Chandrasekhara; Gregory G Ginsberg
Journal:  Curr Gastroenterol Rep       Date:  2011-12

2.  KIT and PDGFRA in esophageal pure small cell carcinoma.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

3.  Gastrointestinal stromal tumors (GISTs): an imaging perspective.

Authors:  Shahina Bano; Sunil Kumar Puri; Lalendra Upreti; Vikas Chaudhary; Hridesh Kumar Sant; Ranjana Gondal
Journal:  Jpn J Radiol       Date:  2011-12-22       Impact factor: 2.374

4.  [Molecular biological evaluation of prognostic parameters in GIST. Development of an integrative model of tumor progression].

Authors:  F Haller
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

5.  NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Cristina R Antonescu; Ronald P DeMatteo; Kristen N Ganjoo; Robert G Maki; Peter W T Pisters; Chandrajit P Raut; Richard F Riedel; Scott Schuetze; Hema M Sundar; Jonathan C Trent; Jeffrey D Wayne
Journal:  J Natl Compr Canc Netw       Date:  2010-04       Impact factor: 11.908

6.  [Gastrointestinal stromal tumors of the stomach. Updates and differences compared to other locations].

Authors:  E Wardelmann; P Hohenberger; P Reichardt; S Merkelbach-Bruse; H-U Schildhaus; R Büttner
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

7.  Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.

Authors:  J F Emile; S Brahimi; J M Coindre; P P Bringuier; G Monges; P Samb; L Doucet; I Hostein; B Landi; M P Buisine; A Neuville; O Bouché; P Cervera; J L Pretet; J Tisserand; A Gauthier; A Le Cesne; J C Sabourin; J Y Scoazec; S Bonvalot; C L Corless; M C Heinrich; J Y Blay; P Aegerter
Journal:  Med Oncol       Date:  2011-09-28       Impact factor: 3.064

Review 8.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

9.  Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation.

Authors:  Abbas Agaimy; Andreas Gaumann; Josef Schroeder; Wolfgang Dietmaier; Arndt Hartmann; Ferdinand Hofstaedter; Peter H Wünsch; Thomas Mentzel
Journal:  Virchows Arch       Date:  2007-09-14       Impact factor: 4.064

10.  Gastrointestinal stromal tumors (GISTs): SEAP-SEOM consensus on pathologic and molecular diagnosis.

Authors:  J Martin-Broto; V Martinez-Marín; C Serrano; N Hindi; J A López-Guerrero; R Ramos-Asensio; A Vallejo-Benítez; D Marcilla-Plaza; R González-Cámpora
Journal:  Clin Transl Oncol       Date:  2016-12-09       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.